Navigation Links
New Drug Therapy for Breast Cancer Offers Hope

According to scientists, switching over from the standard breast cancer therapy drug tamoxifen, to another one exemestane//, could cut related deaths by almost one-fifths.

Publishing their findings in the online version of The Lancet, researchers Dr. Francesco Boccardo of the National Cancer Research Institute, UK, and team, stood for changing treatments tracks to exemestane after 2 or 3 years of tamoxifen. This so, as it reduced deaths by 17 percent.

Their findings stem from a study of 4,742 women who were treated for a total of five years and monitored for another three.

The subjects were randomly assigned either to a full five years of tamoxifen, or treatment with tamoxifen followed by exemestane.

Giving women tamoxifen after surgery already reduced the risk of dying by 33 per cent compared with no treatment. After another two to three years of exemestane and a further three years of post-treatment follow-up, survival was found to be significantly improved.

The chances of dying were now 50 per cent lower than they would have been with no chemotherapy, and 17 per cent lower than they were, without the switch over from tamoxifen.

Exemestane belongs to a group of aromatase inhibitors. They are a newer class of drugs and include the medicines Femara, Aromasin, and Arimidex.

These fight cancer cell growth in a different way by blocking the workings of an aromatase enzyme while also reducing estrogen.

Around 31,000 post-menopausal women are diagnosed with breast cancer in the UK each year. In 80 to 85 per cent of these cases, the disease is promoted by estrogen.

While tamoxifen interferes with the activity of the hormone, exemestane reduces the levels produced in a woman's body.

In addition, it was observed that patients treated with exemestane were 25 per cent less likely to see their cancer return than those who remained on tamoxifen.

Says Dr. Mary McCorm
'"/>




Page: 1 2

Related medicine news :

1. Cancer Doctors Okays Controversial Prostate Therapy
2. Consensus on "Combination Therapy" for Breast Cancer
3. Gene Therapy shows promise in treating Hemophilia
4. "Make AIDS Therapy affordable" - Physicians demand
5. Hormone replacement Therapy a headache
6. Simple Therapy
7. Therapy for stopping the spread of cancer cells
8. Gene Therapy Destroys Pancreatic Cancer Cells
9. Letrozole Beats Tamoxifen in Breast Cancer Therapy
10. Garlic Supplements Impede HIV Therapy
11. Gene Therapy For Cystic Fibrosis
Post Your Comments:
(Date:12/5/2009)... There have been significant scientific advances in the field ... a better understanding of how certain diseases progress in ... with the best care. Research presented today at the ... explores optimal induction therapies for managing multiple myeloma, the ...
(Date:12/5/2009)... ORLEANS, Dec. 5 Leukemia and myeloproliferative disorders ... presented today at the 51st Annual Meeting of ... treatment options and improved diagnostic methods for patients ... infant acute lymphoblastic leukemia, and myelofibrosis that are ...
(Date:12/5/2009)... an innovative new international private medical insurance plan which follows the ... customers the flexibility to add or remove a wide range of ... to tailor their benefits to complement those already offered in their ... ...
(Date:12/4/2009)... Care Investment Trust Inc. (NYSE: CRE ) ... has declared a dividend of $0.17 per share of common stock. ... shareholders of record on December 14, 2009. ,, ... is a real estate investment and finance company investing in healthcare-related ...
(Date:12/4/2009)... Association of Homes and Services for the Aging (AAHSA) applauds ... Supportive Services (CLASS) provisions remain in the final health reform ... to elders, people with disabilities and their caregivers. ,, ... bill that will make it affordable to care for families ...
Breaking Medicine News(10 mins):Health News:New Research Demonstrates Advances in Optimizing Treatments and Quality of Life for People With Hard-To-Treat Forms of Blood Cancer 2Health News:New Research Demonstrates Advances in Optimizing Treatments and Quality of Life for People With Hard-To-Treat Forms of Blood Cancer 3Health News:New Research Demonstrates Advances in Optimizing Treatments and Quality of Life for People With Hard-To-Treat Forms of Blood Cancer 4Health News:New Research Demonstrates Advances in Optimizing Treatments and Quality of Life for People With Hard-To-Treat Forms of Blood Cancer 5Health News:New Research Demonstrates Advances in Optimizing Treatments and Quality of Life for People With Hard-To-Treat Forms of Blood Cancer 6Health News:New Research Demonstrates Advances in Optimizing Treatments and Quality of Life for People With Hard-To-Treat Forms of Blood Cancer 7Health News:New Research Demonstrates Advances in Optimizing Treatments and Quality of Life for People With Hard-To-Treat Forms of Blood Cancer 8Health News:Advances in Genetic Understanding and Treatment Protocols Lead to Significant Progress in Leukemia and Myeloproliferative Disorders 2Health News:Advances in Genetic Understanding and Treatment Protocols Lead to Significant Progress in Leukemia and Myeloproliferative Disorders 3Health News:Advances in Genetic Understanding and Treatment Protocols Lead to Significant Progress in Leukemia and Myeloproliferative Disorders 4Health News:Advances in Genetic Understanding and Treatment Protocols Lead to Significant Progress in Leukemia and Myeloproliferative Disorders 5Health News:Advances in Genetic Understanding and Treatment Protocols Lead to Significant Progress in Leukemia and Myeloproliferative Disorders 6Health News:Advances in Genetic Understanding and Treatment Protocols Lead to Significant Progress in Leukemia and Myeloproliferative Disorders 7Health News:Advances in Genetic Understanding and Treatment Protocols Lead to Significant Progress in Leukemia and Myeloproliferative Disorders 8Health News:Advances in Genetic Understanding and Treatment Protocols Lead to Significant Progress in Leukemia and Myeloproliferative Disorders 9Health News:AVIVA's Private Health Insurance Products Solutions Go International 2Health News:Care Investment Trust Inc. Declares Quarterly Dividend of $0.17 Per Share 2
... northern Illinois is declining due to improved care for ... , But not everyone is reaping the benefits. ... of Medicine has found people in African American communities ... times higher rate of lower limb amputations than people ...
... ... oncology, MEMPHIS, ... company specializing in,oncology, issued the following statement today regarding the impact ... PRO information in the community oncology setting,and timely intervention can significantly ...
... new era of custom exercise routines online at ... TNL24-7.com officially,launched its Web-based, customizable workout software ... anyone, regardless of fitness level, to,take charge of ... TNL24-7 allows anyone to create a professional ...
... Auction, OREM, Utah, April 28 Friday,s Kids ... holding its,first annual Lifting Angels Auction the week leading ... to auction, Friday,s Kids, goal is to,raise $15,000 to ... needs. As the major fundraising campaign, the auction will,attract ...
... 28, 2008 How frequently do doctors misdiagnose patients? ... medical diagnoses are correct, the answer is probably higher ... In a Supplement to the May issue of The ... commentaries sheds light on the causes underlying misdiagnoses and ...
... NORTH HOLLYWOOD, Calif., April 28 IPC The,Hospitalist Company, ... practice company, announced today that Adam D. Singer, Chief,Executive ... 2008 at the,33rd Annual Deutsche Bank Health Care Conference ... will also be present at the,conference., Event: ...
Other Medicine News:Health News:African Americans have 5 times higher amputation rate 2Health News:Systematic Review of Patient-Reported Outcomes (PROs) Can Reduce Cost of Cancer Care 2Health News:Friday's Kids Respite Holds Fundraising Event to Help Children with Special Needs 2Health News:Will you be misdiagnosed? -- how diagnostic errors happen 2Health News:Will you be misdiagnosed? -- how diagnostic errors happen 3Health News:IPC The Hospitalist Company, Inc. to Present at the 33rd Annual Deutsche Bank Health Care Conference 2
(Date:12/4/2009)... DURHAM, N.C., Dec. 4 Oxygen Biotherapeutics, Inc. (OTC ... has been enrolled in the company,s Phase II-b, dose ... emulsion in traumatic brain injury (TBI). Oxycyte is the ... is of invaluable importance in improving the outcome of ...
(Date:12/4/2009)... 4 Shared Imaging, LLC, an independent provider ... programs for hospitals and healthcare providers, is excited ... Accreditation for Ambulatory Health Care, a nationally-recognized, prestigious ... in patient care. Shared Imaging accreditation is system-wide ...
(Date:12/4/2009)... highlighted a new report published by the ... that identifies 97 new drugs and vaccines in development for ... that the 97 products in development include 23 vaccines and ... or awaiting approval by the U.S. Food and Drug Administration ...
Breaking Medicine Technology:Oxygen Biotherapeutics, Inc. Enrolls First Patient in Traumatic Brain Injury Clinical Trial in Switzerland 2Shared Imaging Earns The Joint Commission's Accreditation for Ambulatory Health Care 2U.S. Pharmaceutical Companies Developing 97 New Drugs and Vaccines to Fight HIV/AIDS 2For Healthy Aging Maintaining Muscle is a Must 54179 1For Healthy Aging Maintaining Muscle is a Must 54179 2For Healthy Aging Maintaining Muscle is a Must 54179 3Advanced Life Sciences Announces Second Quarter 2009 Financial Results and Financial Outlook 13497 1Advanced Life Sciences Announces Second Quarter 2009 Financial Results and Financial Outlook 13497 2Advanced Life Sciences Announces Second Quarter 2009 Financial Results and Financial Outlook 13497 3Advanced Life Sciences Announces Second Quarter 2009 Financial Results and Financial Outlook 13497 4Advanced Life Sciences Announces Second Quarter 2009 Financial Results and Financial Outlook 13497 5Advanced Life Sciences Announces Second Quarter 2009 Financial Results and Financial Outlook 13497 6Advanced Life Sciences Announces Second Quarter 2009 Financial Results and Financial Outlook 13497 7Advanced Life Sciences Announces Second Quarter 2009 Financial Results and Financial Outlook 13497 8Advanced Life Sciences Announces Second Quarter 2009 Financial Results and Financial Outlook 13497 9Kathleen Kalafs Atlantic Journey to Wellness Raises Awareness of Systemic Candida and Gains Sponsorship of Renowned Photographer Peter Simon 54174 1Kathleen Kalafs Atlantic Journey to Wellness Raises Awareness of Systemic Candida and Gains Sponsorship of Renowned Photographer Peter Simon 54174 2Kathleen Kalafs Atlantic Journey to Wellness Raises Awareness of Systemic Candida and Gains Sponsorship of Renowned Photographer Peter Simon 54174 3
... N.C., Jan. 26 Mardil Inc., a cardiac ... valve regurgitation, has successfully advanced its device to ... company. The first patient was successfully implanted with ... patient had a significant improvement in heart function ...
... efficacy to Avastin alone and in combination with ... results seen in Previous Breast Cancer ModelDALLAS, Jan. ... ACCP) presented new data this week on its ... Angiolix(R) binds with high affinity to the its ...
Other Medicine Technology:Mardil Inc. Advances Its Novel Cardiac Device to First-In-Human Trials for Mitral Valve Regurgitation 2Access Pharmaceuticals Presents new Combination Data on the Company's Angiolix(R) Therapeutic Monoclonal Antibody 2Access Pharmaceuticals Presents new Combination Data on the Company's Angiolix(R) Therapeutic Monoclonal Antibody 3
... This control is intended as a ... testing methods. A new feature is ... CRP. It is compatible with most ... ACS:180, Access, Dimension, Elecsys, Stratus and ...
... ResMeds premium APAP device in the S8 ... patients pressure needs on a breath-by-breath basis. ... fully integrated humidification and also include remote ... patients time by reducing medical visits. Like ...
... AutoSet Spirit is the premium APAP device ... S7. The AutoSet algorithm responds to the ... The flow generator stores and reports comprehensive ... The AutoSet devices combine integrated humidification and ...
Paediatric tubes have decreased sample volumes and are ideal for small childrens' veins and geriatric patients....
Medicine Products: